Advertisement

Topics

Latest "Approves Cardio Revolutionary Diagnostic Heart Device" News Stories

06:38 EDT 22nd May 2018 | BioPortfolio

Here are the most relevant search results for "Approves Cardio Revolutionary Diagnostic Heart Device" found in our extensive news archives from over 250 global news sources.

More Information about Approves Cardio Revolutionary Diagnostic Heart Device on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Approves Cardio Revolutionary Diagnostic Heart Device for you to read. Along with our medical data and news we also list Approves Cardio Revolutionary Diagnostic Heart Device Clinical Trials, which are updated daily. BioPortfolio also has a large database of Approves Cardio Revolutionary Diagnostic Heart Device Companies for you to search.

Showing "Approves Cardio Revolutionary Diagnostic Heart Device" News Articles 1–25 of 10,000+

Tuesday 22nd May 2018

TeleWellnessMD™ Launches New Text Alert Program - VIP Mobile Club

The telehealth services company is improving the user experience for their clients through a new text alert program for improved communications. Other improvements include increased flexibility in appointment scheduling and more affordable pricing for prescription therapies. CLEARWATER, Fla. (PRWEB) May 22, 2018 TeleWellnessMD™ - a telehealth services company that provides wellness-based medic...


Large-Scale Body Composition Study Reveals Link between Specific Fat Distributions and Metabolic Diseases

New study in Obesity reveals metabolic phenotypes described by skewed body fat distributions Specific patterns of fat distribution are linked to the presence of Coronary Heart Disease (CHD) and Type 2 Diabetes (T2D), according to a new study published in Obesity.1 AMRA, the international leader in body composition analysis, today announced the r...

Nexstim Plc - first NBT® system for depression ordered in the US

Company announcement, Helsinki, 22 May 2018, at 9:00 AMNexstim Plc - first NBT® system for depression ordered in the US Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted neuromodulation company developing and commercializing its world-leading navigated non-invasive brain stimulation technology for therapeutic and diagnostic applications...


Turning 33,000 Employees into an Agile Pharma Start-up

Digital is changing almost every aspect of healthcare including pharmaceutical manufacturing and distribution. Join Daniel J. Gandor, Director of Digital Innovation for Takeda Pharmaceuticals U.S.A., Inc. and Brad Ansley, Director of SPI Health as they look at the ways digital is changing pharma and the impact on commercial functions. CHARLOTTE, N.C. (PRWEB) May 22, 2018 Digital is changing almo...

FDA approves Dova’s Doptelet for thrombocytopenia in adults with CLD

Dova Pharmaceuticals’ subsidiary AkaRx has secured approval from the US Food and Drug Administration (FDA) for its Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in patients with chronic liver disease (CLD).

HRS 2018 Wrap-Up: Tendril Lead Failures; Metaanalysis of Contact-Force Catheter; LuxCath's OmniView; More Micra Results

The 2018 Heart Rhythm Society scientific sessions in Boston covered a variety of presentations of new electrophysiology clinical data, including...   

Monday 21st May 2018

Orion Corporation ORNBV Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 19022018] Prices from USD $250

SummaryOrion Corporation Orion is a developer of pharmaceuticals and diagnostic tests. The company develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients APIs and diagnostic tests. It focuses on developing pharmaceutical products for central nervous system disorders, cancer and respiratory. Orion's client base consists of healthcare service provi...

Legend Capital Closes $156 Million Phase II for RMB Healthcare Fund

Legend Capital, the controlling shareholder of Lenovo Group, completed a $156 million capital raise for its RMB China healthcare fund. The fund will invest in innovative medicines, precise treatments, medical devices, diagnostic technologies, medical services and genetic technologies. This is the second phase of the RMB healthcare fund, which closed its first fundraising last year. The second phas...

AVITA Medical Announces Presentation at ISPOR Meeting Validating Acute Burn Health Economic Model

Presentation describes development and corroboration of health economic model that has demonstrated cost savings associated with the use of the RECELL® Device AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced that results from a study validating the predicted outcomes and costs from an acute burns

Procedure plus medication is better than standard treatment for heart disease patients

(St. Michael's Hospital) A non-surgical procedure, called percutaneous coronary intervention (PCI), along with prescribed medication, is better than medication alone as initial treatment for people who have the most common form of heart disease, suggests an analysis of an international clinical trial co-led by St. Michael's Hospital.

SYNTAX III Revolution trial

(PCR) Results from the innovative SYNTAX III Revolution trial underline the effectiveness of evolving non-invasive algorithms for Heart Team decision making using state-of-the-art imaging. A distinctive clinical trial in that it randomised the doctors -- in this case, the Heart Team -- rather than the patient, the goal was to better understand the present and future role that non-invasive assessme...

Aerosol Spray Treats Gastrointestinal Bleeds

A novel device helps control hemorrhage within the upper and lower gastrointestinal (GI) tract, such as those caused by gastric...

Mediterranean diet may protect people from negative effects of air pollution

Eating a Mediterranean diet may protect people from some of the harm of long-term exposure to air pollution, and reduce their risk of dying from heart attacks, stroke and other causes of death, according to new research presented at the ATS 2018 International Conference.

Sino Agro Food, Inc. Reports Q1 2018 Results and Board Approves Dividend

Under the advisement of its Board of Directors, the Company has decided to issue the following cash dividends for Fiscal Years 2018 and 2019:     For Read more...

Ongoing Assessment of Fluid Responsiveness Provides Indication of Cardiac Functions in Septic Patients

Data leveraging Cheetah technology presented at the American Thoracic Society International Conference 2018 in San Diego Cheetah Medical, a Massachusetts-based leader in non-invasive fluid management devices, today announced that research results leveraging Cheetah technology were presented at the American Thoracic Society (ATS) International Conferenc...

FDA Approves Prolia® (Denosumab) For Glucocorticoid-Induced Osteoporosis

Fifth Indication for Prolia for Men and Women at High Risk of Fracture Receiving Systemic Glucocorticoid Therapy THOUSAND OAKS, Calif., May 21, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the use of Prolia® (denosumab) for the treatment of glucocorticoid-induced osteoporosis (GIOP) in men and women at high risk of fra...

Patients Suffer as a Renowned Heart Transplant Program Loses Its Luster

The hospital and its legendary surgeon Denton Cooley performed some of the world’s first heart transplants back in the 1960s. In recent years, though, it has had some of the worst heart transplant outcomes in the country. ProPublica

Egg a day tied to lower risk of heart disease

(Reuters Health) - People who eat an egg just about every day may have a lower risk of heart attack and stroke than individuals who don't eat eggs at all, a large Chinese study suggests.

Eggs Are Good for the Heart... or Not

(MedPage Today) -- Here's why dietary epidemiology research can be rotten

FDA Approves New Drug For Patients With Chronic Liver Disease

NewsThe FDA today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. This is the first drug approved by the FDA for this use.

Your NEJM Group Today: Raindrop Skull Image / Heart Disease & Pregnancy Complications / Ohio Family Medicine Opportunities

Here's what we chose for you from NEJM Group today: NEJM Primary Care/Hospitalist Page: Images in clinical medicine: A 46-year-old man presented...

CPAP Lowered Heart Rate in Prediabetics with Sleep Apnea

(MedPage Today) -- Magnitude of reductions in comparable to beta-blockers, researchers say

Global firm Hitachi chooses Sci-Tech Daresbury to expand UK presence

Hitachi High-Technologies (Europe), part of Japan’s Hitachi Group,is taking laboratory space in the campus’s newest building, Techspace One to set up its UK demonstration laboratory facility for its electron microscopy division. An international leading–edge technology company has chosen Sci-Tech Daresbury as its scientific base in the UK.Hitachi High-Technologies (Europe) is par...

Hypogonadal Men See Better Heart Health on Testosterone Tx

(MedPage Today) -- Fewer deaths due to MACE seen over 10 years versus controls

Lab-Grown Heart Cells Managed by Remote Control

NewsGraphene surface allows researchers to control cell behavior with light — a technique that could speed the search for more precise, less toxic therapeutic drugs.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks